drugset / Trial / NCT04818229
A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study will investigate the effects of therapeutic and supratherapeutic oral doses of CBP-307 on the QTc interval in healthy subjects.
Timeline
- Start
- 2021-06-01
- Primary completion
- 2022-03-20
- Completion
- 2022-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBP-307 | Unknown | — | Oral |
| Comparator | Moxifloxacin | Small molecule | — | Oral |